- Home
- HUDI vs CRIS Comparison
HUDI vs CRIS Comparison
Compare HUDI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUDI | CRIS |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 14.0M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | HUDI | CRIS |
|---|---|---|
| Price | $1.21 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 25.7K | ★ 123.5K |
| Earning Date | 01-30-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $32.24 |
| Revenue Next Year | N/A | $66.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $1.06 | $0.75 |
| 52 Week High | $5.46 | $3.13 |
Technical Indicators
Market Signals| Indicator | HUDI | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 26.27 |
| Support Level | $1.09 | N/A |
| Resistance Level | $1.30 | $1.04 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 30.23 | 8.21 |
Price Performance
Historical ComparisonAbout HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.